Business Description
![Canntab Therapeutics Ltd Canntab Therapeutics Ltd logo](https://static.gurufocus.com/logos/0C00008PF3.png?14)
Canntab Therapeutics Ltd
NAICS : 325412
SIC : 3741
ISIN : CA1377991023
Compare
Compare
Traded in other countries / regions
CTABF.USAPILL.CanadaTBF1.Germany IPO Date
2014-09-04Description
Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.29 | |||||
14-Day RSI | 92.53 | |||||
6-1 Month Momentum % | -18.89 | |||||
12-1 Month Momentum % | -45.93 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -1886.21 |
GF Value Rank
Name | Current | Vs Industry | Vs History |
---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CTABF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Canntab Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.058 | ||
EPS (TTM) ($) | -0.068 | ||
Beta | 2.34 | ||
Volatility % | 459.95 | ||
14-Day RSI | 92.53 | ||
14-Day ATR ($) | 0.000038 | ||
20-Day SMA ($) | 0.00849 | ||
12-1 Month Momentum % | -45.93 | ||
52-Week Range ($) | 0.0016 - 0.0135 | ||
Shares Outstanding (Mil) | 38.91 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Canntab Therapeutics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Canntab Therapeutics Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Canntab Therapeutics Ltd Frequently Asked Questions
What is Canntab Therapeutics Ltd(CTABF)'s stock price today?
The current price of CTABF is $0.01. The 52 week high of CTABF is $0.01 and 52 week low is $0.00.
When is next earnings date of Canntab Therapeutics Ltd(CTABF)?
The next earnings date of Canntab Therapeutics Ltd(CTABF) is 0.
Does Canntab Therapeutics Ltd(CTABF) pay dividends? If so, how much?
Canntab Therapeutics Ltd(CTABF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |